Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recruiting Phase 1 / 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0029923 (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01904136Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaTreatment